2020
DOI: 10.1007/s41999-020-00319-w
|View full text |Cite|
|
Sign up to set email alerts
|

Do direct oral anticoagulants (DOACs) cause delayed surgery, longer length of hospital stay, and poorer outcome for hip fracture patients?

Abstract: The aim of this study was to determine whether DOAC-users with a hip fracture have delayed surgery, longer length of hospital stay or altered risk of bleeding complications compared to non-users. Findings DOAC-users with a hip fracture did not have increased surgical delay, length of stay or risk of reported bleeding complications compared to patients without anticoagulation prior to surgery. Message Our study does not support delayed surgery for DOAC-users suffering a hip fracture.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

6
42
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 29 publications
(48 citation statements)
references
References 38 publications
6
42
0
Order By: Relevance
“…Although more patients were taking VKA in 2016, a shift to DOACs was observed, such that more patients were taking DOACs in 2018. A 15% prevalence of anticoagulation with DOACs was recently described in a patient cohort from 2016 to 2017 among patients with proximal femur fractures [ 14 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although more patients were taking VKA in 2016, a shift to DOACs was observed, such that more patients were taking DOACs in 2018. A 15% prevalence of anticoagulation with DOACs was recently described in a patient cohort from 2016 to 2017 among patients with proximal femur fractures [ 14 ].…”
Section: Discussionmentioning
confidence: 99%
“…The uncertainty in perioperative handling of these substances is increased by the lack of consensus on the appropriate drug-free interval until hip fracture surgery [ 2 ]. Overall, several authors advocate for early surgery even in DOAC users, as they did not find increased bleeding and transfusion rates in these patients compared to non-anticoagulated patients [ 14 , 20 ]…”
Section: Discussionmentioning
confidence: 99%
“…In six (33.3%) studies in this review [26,[37][38][39][40][41], a matched comparison group was used or data were matched post hoc, but matching criteria were not consistent across studies, nor were consistent comparator groups used. Where matching was not used, only six (40.0%) studies specified and adjusted for potential covariates [42][43][44][45][46][47], indicating potential limitations of sample size to conduct regression analyses. In ten (47.6%) studies, there were less than 50 patients taking DOACs.…”
Section: Discussionmentioning
confidence: 99%
“…This situation clearly translates into an accumulating body of evidence that subjects taking DOACs experience more frequent delays in HF surgery with a subsequent increase in mortality [57]. Notwithstanding this difficulty, many studies have highlighted that these patients do not present significant [58][59][60] increase in post-operative bleeding [58][59][60][61] or higher occurrence of major haemorrhage or death. A relevant factor to carefully consider in this respect is kidney function.…”
Section: Management Of Anticoagulant Therapymentioning
confidence: 99%